AbbVie and REGENXBIO form a strategic partnership combining eye care and gene therapy expertise

AbbVie and REGENXBIO form a strategic partnership combining eye care and gene therapy expertise

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) announced a partnership to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and other chronic retinal diseases. RGX-314 is currently being evaluated in patients with wet AMD in a pivotal trial utilizing subretinal delivery, and in patients with wet AMD and DR in two separate Phase II clinical trials utilizing in-office suprachoroidal delivery. Under the collaboration, REGENXBIO will be responsible for completion of the ongoing trials of RGX-314. AbbVie and REGENXBIO will collaborate and share costs on additional trials of RGX-314, including the planned second pivotal ...
Read More
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

ProQR Therapeutics N.V. (Nasdaq: PRQR) announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The companies will use ProQR’s proprietary Axiomer® RNA editing platform to progress new drug targets toward clinical development and commercialization. ProQR’s unique Axiomer® platform technology enables the editing of single nucleotides in RNA in a highly targeted and specific manner. The technology is based on editing oligonucleotides, or EONs, designed to recruit endogenous ADAR enzymes (Adenosine Deaminases Acting on RNA) to a selected target ...
Read More
Party casino - the best roulette for money

Party casino – the best roulette for money

Table of Contents Convenient site party casino What slots are in the casino Party casino bonuses - roulette and slots Finance Department How to register Casino for money: the choice of entertainment Withdrawal of funds Party casino is a proven online casino for money, which guarantees fair payouts and a rich selection of slot machines. The site of the casino has an intuitive design - all the main sections are on the main page. One of the leading areas of the casino is roulettes. There is a huge number of them - you can find both classic and modern variants ...
Read More
Roche and Shape Therapeutics sign gene therapy development deal

Roche and Shape Therapeutics sign gene therapy development deal

Shape Therapeutics has signed a multi-target strategic partnership and licence agreement with Roche to develop gene therapy for specific targets in Alzheimer’s disease, Parkinson’s disease, and rare disease areas. The deal means Shape is eligible to more than $3bn from Roche in initial and potential payments on meeting development, regulatory and sales milestones. Shape is also entitled to tiered royalty payments on future sales of products developed through the partnership. The preclinical activities to detect potential candidates will be conducted by Shape using its RNAfix and AAVid platforms. For further information, see Pharmaceutical Technology (https://www.pharmaceutical-technology.com/news/roche-shape-gene-therapy-deal/) ...
Read More
Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, announced on August 24th a multi-target strategic collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY). Through this partnership ShapeTX will apply its proprietary RNA editing platform RNAfix™ and potentially leverage its AAVid™ technology platform for next-generation tissue-specific adeno-associated viruses (AAVs) for the development of gene therapy for certain targets in the areas of Alzheimer’s disease, Parkinson’s disease, and rare diseases. During the course of the partnership, ShapeTX will conduct preclinical research to identify and deliver development candidates discovered by its AI-powered platforms RNAfix™ and, potentially, ...
Read More
Lucky nugget casino - when you want to have fun and relax

Lucky nugget casino – when you want to have fun and relax

Content Advantages of the new slot machines What are good virtual sites? Playing for money signs Lucky nugget casino - modern slot machines The fairy tale of excitement during online recreation Pleasant conditions for recreation According to users of the network, slot machines online in the club Lucky nugget casino deserves the title of the best tool for leisure. Many of our contemporaries, who are in dire need of new experiences and a rush of adrenaline in the blood, gambling fun to use as an effective way to make money. Advantages of the new slot machines Lucky nugget casino - ...
Read More
China's mRNA vaccine technology firm Abogen raises over $700M

China’s mRNA vaccine technology firm Abogen raises over $700M

China's Suzhou Abogen Biosciences said on August 19th that it has raised over $700 million to support clinical development of its potential COVID-19 vaccine and expand pipeline of other vaccine and treatment candidates. Abogen's potential shot against the new coronavirus, which it is jointly developing with a research institute affiliated with Chinese military and Walvax Biotechnology (300142.SZ), adopts the messenger RNA (mRNA) technology. The candidate ARCoV is being tested in a Phase III clinical trial. The fundraising was led by seven investors, including Singapore's state investment firm Temasek Holdings [RIC:RIC:TEM.UL] and Hillhouse-backed GL ventures, Abogen said in a statement. For further ...
Read More

AbbVie and REGENXBIO form a strategic partnership combining eye care and gene therapy expertise

AbbVie and REGENXBIO form a strategic partnership combining eye care and gene therapy expertise

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) announced a partnership to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and other chronic retinal diseases. RGX-314 is currently being evaluated in patients with wet AMD in a pivotal trial utilizing subretinal delivery, and in patients with wet AMD and DR in two separate Phase II clinical trials utilizing in-office suprachoroidal delivery. Under the collaboration, REGENXBIO will be responsible for completion of the ongoing trials of RGX-314. AbbVie and REGENXBIO will collaborate and share costs on additional trials of RGX-314, including the planned second pivotal ...
Read More
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

ProQR Therapeutics N.V. (Nasdaq: PRQR) announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The companies will use ProQR’s proprietary Axiomer® RNA editing platform to progress new drug targets toward clinical development and commercialization. ProQR’s unique Axiomer® platform technology enables the editing of single nucleotides in RNA in a highly targeted and specific manner. The technology is based on editing oligonucleotides, or EONs, designed to recruit endogenous ADAR enzymes (Adenosine Deaminases Acting on RNA) to a selected target ...
Read More
Party casino - the best roulette for money

Party casino – the best roulette for money

Table of Contents Convenient site party casino What slots are in the casino Party casino bonuses - roulette and slots Finance Department How to register Casino for money: the choice of entertainment Withdrawal of funds Party casino is a proven online casino for money, which guarantees fair payouts and a rich selection of slot machines. The site of the casino has an intuitive design - all the main sections are on the main page. One of the leading areas of the casino is roulettes. There is a huge number of them - you can find both classic and modern variants ...
Read More
Roche and Shape Therapeutics sign gene therapy development deal

Roche and Shape Therapeutics sign gene therapy development deal

Shape Therapeutics has signed a multi-target strategic partnership and licence agreement with Roche to develop gene therapy for specific targets in Alzheimer’s disease, Parkinson’s disease, and rare disease areas. The deal means Shape is eligible to more than $3bn from Roche in initial and potential payments on meeting development, regulatory and sales milestones. Shape is also entitled to tiered royalty payments on future sales of products developed through the partnership. The preclinical activities to detect potential candidates will be conducted by Shape using its RNAfix and AAVid platforms. For further information, see Pharmaceutical Technology (https://www.pharmaceutical-technology.com/news/roche-shape-gene-therapy-deal/) ...
Read More
Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, announced on August 24th a multi-target strategic collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY). Through this partnership ShapeTX will apply its proprietary RNA editing platform RNAfix™ and potentially leverage its AAVid™ technology platform for next-generation tissue-specific adeno-associated viruses (AAVs) for the development of gene therapy for certain targets in the areas of Alzheimer’s disease, Parkinson’s disease, and rare diseases. During the course of the partnership, ShapeTX will conduct preclinical research to identify and deliver development candidates discovered by its AI-powered platforms RNAfix™ and, potentially, ...
Read More
Lucky nugget casino - when you want to have fun and relax

Lucky nugget casino – when you want to have fun and relax

Content Advantages of the new slot machines What are good virtual sites? Playing for money signs Lucky nugget casino - modern slot machines The fairy tale of excitement during online recreation Pleasant conditions for recreation According to users of the network, slot machines online in the club Lucky nugget casino deserves the title of the best tool for leisure. Many of our contemporaries, who are in dire need of new experiences and a rush of adrenaline in the blood, gambling fun to use as an effective way to make money. Advantages of the new slot machines Lucky nugget casino - ...
Read More
China's mRNA vaccine technology firm Abogen raises over $700M

China’s mRNA vaccine technology firm Abogen raises over $700M

China's Suzhou Abogen Biosciences said on August 19th that it has raised over $700 million to support clinical development of its potential COVID-19 vaccine and expand pipeline of other vaccine and treatment candidates. Abogen's potential shot against the new coronavirus, which it is jointly developing with a research institute affiliated with Chinese military and Walvax Biotechnology (300142.SZ), adopts the messenger RNA (mRNA) technology. The candidate ARCoV is being tested in a Phase III clinical trial. The fundraising was led by seven investors, including Singapore's state investment firm Temasek Holdings [RIC:RIC:TEM.UL] and Hillhouse-backed GL ventures, Abogen said in a statement. For further ...
Read More
AbbVie and REGENXBIO form a strategic partnership combining eye care and gene therapy expertise

AbbVie and REGENXBIO form a strategic partnership combining eye care and gene therapy expertise

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) announced a partnership to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and other chronic retinal diseases. RGX-314 is currently being evaluated in patients with wet AMD in a pivotal trial utilizing subretinal delivery, and in patients with wet AMD and DR in two separate Phase II clinical trials utilizing in-office suprachoroidal delivery. Under the collaboration, REGENXBIO will be responsible for completion of the ongoing trials of RGX-314. AbbVie and REGENXBIO will collaborate and share costs on additional trials of RGX-314, including the planned second pivotal ...
Read More
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

ProQR Therapeutics N.V. (Nasdaq: PRQR) announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The companies will use ProQR’s proprietary Axiomer® RNA editing platform to progress new drug targets toward clinical development and commercialization. ProQR’s unique Axiomer® platform technology enables the editing of single nucleotides in RNA in a highly targeted and specific manner. The technology is based on editing oligonucleotides, or EONs, designed to recruit endogenous ADAR enzymes (Adenosine Deaminases Acting on RNA) to a selected target ...
Read More
Party casino - the best roulette for money

Party casino – the best roulette for money

Table of Contents Convenient site party casino What slots are in the casino Party casino bonuses - roulette and slots Finance Department How to register Casino for money: the choice of entertainment Withdrawal of funds Party casino is a proven online casino for money, which guarantees fair payouts and a rich selection of slot machines. The site of the casino has an intuitive design - all the main sections are on the main page. One of the leading areas of the casino is roulettes. There is a huge number of them - you can find both classic and modern variants ...
Read More
Roche and Shape Therapeutics sign gene therapy development deal

Roche and Shape Therapeutics sign gene therapy development deal

Shape Therapeutics has signed a multi-target strategic partnership and licence agreement with Roche to develop gene therapy for specific targets in Alzheimer’s disease, Parkinson’s disease, and rare disease areas. The deal means Shape is eligible to more than $3bn from Roche in initial and potential payments on meeting development, regulatory and sales milestones. Shape is also entitled to tiered royalty payments on future sales of products developed through the partnership. The preclinical activities to detect potential candidates will be conducted by Shape using its RNAfix and AAVid platforms. For further information, see Pharmaceutical Technology (https://www.pharmaceutical-technology.com/news/roche-shape-gene-therapy-deal/) ...
Read More
Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications

Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, announced on August 24th a multi-target strategic collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY). Through this partnership ShapeTX will apply its proprietary RNA editing platform RNAfix™ and potentially leverage its AAVid™ technology platform for next-generation tissue-specific adeno-associated viruses (AAVs) for the development of gene therapy for certain targets in the areas of Alzheimer’s disease, Parkinson’s disease, and rare diseases. During the course of the partnership, ShapeTX will conduct preclinical research to identify and deliver development candidates discovered by its AI-powered platforms RNAfix™ and, potentially, ...
Read More
Lucky nugget casino - when you want to have fun and relax

Lucky nugget casino – when you want to have fun and relax

Content Advantages of the new slot machines What are good virtual sites? Playing for money signs Lucky nugget casino - modern slot machines The fairy tale of excitement during online recreation Pleasant conditions for recreation According to users of the network, slot machines online in the club Lucky nugget casino deserves the title of the best tool for leisure. Many of our contemporaries, who are in dire need of new experiences and a rush of adrenaline in the blood, gambling fun to use as an effective way to make money. Advantages of the new slot machines Lucky nugget casino - ...
Read More
China's mRNA vaccine technology firm Abogen raises over $700M

China’s mRNA vaccine technology firm Abogen raises over $700M

China's Suzhou Abogen Biosciences said on August 19th that it has raised over $700 million to support clinical development of its potential COVID-19 vaccine and expand pipeline of other vaccine and treatment candidates. Abogen's potential shot against the new coronavirus, which it is jointly developing with a research institute affiliated with Chinese military and Walvax Biotechnology (300142.SZ), adopts the messenger RNA (mRNA) technology. The candidate ARCoV is being tested in a Phase III clinical trial. The fundraising was led by seven investors, including Singapore's state investment firm Temasek Holdings [RIC:RIC:TEM.UL] and Hillhouse-backed GL ventures, Abogen said in a statement. For further ...
Read More